Kaia Agarwal, Regulatory Principal NDA Group, has been recognized by the RAPs committee for her extensive regulatory background, including her work history, management and leadership experience, knowledge of regulatory issues and, importantly, contributions to the regulatory community.
RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products.
The RAPS Fellows program recognizes senior regulatory professionals for their significant contributions and leadership in advancing the regulatory profession and the Regulatory Affairs Professionals Society (RAPS). In addition, RAPS Fellows are an important resource for helping the organization by supporting mentoring efforts, developing strategic directions, implementing special initiatives and advancing RAPS’ international development efforts.
The RAPs fellowship committee also cited that Kaia’s vision and leadership are recognized and appreciated by her RAPs colleagues and the global regulatory profession.